Bausch Health Companies Inc

€4.683
EUR
Last updated on --.
24h volume1.30M
24h highest4.8083 EUR
24h lowest4.5806 EUR
24h Price movement-0.37%

BHC recent prices

24 Hours
-0.37%-€0.017188
30 days
-1.13%-€0.054142
60 days
+8.96%+€0.38673
90 days
-8.66%-€0.44947

Key data

Previous close4.7009 EUR
Market cap1.77B EUR
Volume1.30M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount0.85940 EUR
Next ex-dividend date10 Nov 2010
Next payment date22 Dec 2010
EPS diluted (TTM)-2.7759 EUR
Net income (FY)-1.05B EUR
Revenue (FY)9.05B EUR
Last report date30 Apr 2026

About Bausch Health Companies Inc

PHARMACEUTICAL PREPARATIONS
HeadquartersQUEBEC
Employees (FY)20.30K
Revenue per employee (FY)445.83K EUR
Net income per employee (FY)-51.86K EUR
Listed onNew York Stock Exchange
Official website

BHC conversion tables

BHCBHC
EUREUR
0.5 BHC2.341 EUR
1 BHC4.683 EUR
5 BHC23.41 EUR
10 BHC46.83 EUR
EUREUR
BHCBHC
0.5 EUR0.10675 BHC
1 EUR0.21351 BHC
5 EUR1.067 BHC
10 EUR2.135 BHC

FAQ

BHC is trading at €4.683, -0.37% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BHC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BHC is currently trading at €4.683, -0.37% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BHC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BHC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BHC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BHC's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Bausch Health Companies Inc's market cap is currently 1.77B EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.30M
24h highest4.8083 EUR
24h lowest4.5806 EUR
24h Price movement-0.37%
BHCBHC
EUREUR
Start trade with BHC Perpetual